Moderna Inc 's Revenue in the fiscal year 2025 $ 1,944.00 millions
Moderna Inc 's Revenue in the fiscal year 2024 $ 3,236.00 millions
Moderna Inc 's Revenue in the fiscal year 2023 $ 6,848.00 millions
Moderna Inc 's Revenue in the fiscal year 2022 $ 19,263.00 millions
Moderna Inc 's Revenue in the fiscal year 2021 $ 18,471.00 millions
MRNA Revenue third quarter 2026 Y/Y Growth Comment
Moderna Inc reported Revenue improvement of 29.23% year on year in the third quarter 2026, to $ 1,313.00 millions, this is lower than Moderna Inc 's recent average Revenue surge of 25936.29%.
Looking into third quarter 2026 results within Biotechnology & Pharmaceuticals industry 41 other companies have achieved higher Revenue growth. While Moderna Inc ' s Revenue rise of 29.23% ranks overall at the positon no. 2586 in the third quarter 2026.
Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026
Moderna Inc 's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
6255.3 %
270.4 %
-100 %
(Mar 31 2020)
MRNA's III. Quarter Q/Q Revenue Comment
Moderna Inc achieved in the III. Quarter 2026 above company average sequential Revenue doubling of 805.52%, to $ 1,313.00 millions, from $145.00 millions in the second quarter. MRNA is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within Biotechnology & Pharmaceuticals industry 60 other companies have achieved higher Revenue quarter on quarter growth. While Moderna Inc 's Revenue growth quarter on quarter, overall rank is 3772.
Moderna Inc achieved in the III. Quarter 2026 above company average sequential Revenue doubling of 805.52%, to $ 1,313.00 millions, from $145.00 millions in the second quarter. MRNA is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within Biotechnology & Pharmaceuticals industry 60 other companies have achieved higher Revenue quarter on quarter growth. While Moderna Inc 's Revenue growth quarter on quarter, overall rank is 3772.
Moderna Inc 's 12 Months Revenue Growth Year on Year
Moderna Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Mar 31 2026. If the fiscal year would end in Jun 30 2026, Moderna Inc 's annual Revenue improvement would be -27.62% year on year to $2,228 millions.
In the Healthcare sector 465 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2527 to 3402.
Moderna Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Mar 31 2026. If the fiscal year would end in Jun 30 2026, Moderna Inc 's annual Revenue drop would be -27.62% year on year to $2,228 millions.
In the Healthcare sector 465 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2527 to 3402.
About Moderna Inc Revenue Growth Rates (MRNA), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
51.12%